Search

everythinglearnresearchcommunity

for

Search:↓

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

Daughters with affected mothers may develop frontal fibrosing alopecia early.

Finasteride was more effective than hydroxychloroquine in treating frontal fibrosing alopecia.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

A 20-year-old woman was found to have a rare ovarian tumor causing symptoms like acne and a low-pitched voice, which disappeared after the tumor was removed.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

Accurate diagnosis of rare hyperandrogenism conditions requires detailed testing and sometimes invasive procedures.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

Removing a testosterone-producing tumor cured a woman's sleep apnea and other symptoms.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Menopause causes dry skin, wrinkles, and hair changes, with hormone therapy helping but not recommended just for these issues.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

Vaginal surgeries generally did not significantly change women's sexual quality of life.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

There is unequal access to gender-affirming surgeries in Canada, with a need for better coverage and specialized programs.

Ovarian vein sampling helped diagnose rare ovarian tumors causing high testosterone, and surgery to remove the tumors lowered the testosterone levels.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Benign conditions can mimic serious ones in postmenopausal hyperandrogenism, requiring careful diagnosis.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Barbed sutures improve surgical outcomes and efficiency but are limited by cost and strength issues.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Sentinel lymph node mapping is safe and effective for early-stage ovarian cancer but isn't yet standard practice.